Literature DB >> 9184185

Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma.

T Rasmuson1, K Grankvist, B Ljungberg.   

Abstract

The soluble ectodomain of c-erbB-2 oncoprotein was measured using a sandwich enzyme immunoassay in sera from 184 patients with renal cell carcinoma before initiation of treatment. The median serum level was 2062 U ml(-1) (range 865-4905 U ml(-1)). Levels were unaffected by sex, age and renal function. An inverse relation between disease stage (P = 0.0017) and tumour grade (P = 0.0009) and the serum level of c-erbB-2 ectodomain was observed. Survival time for patients with serum levels above median level was significantly longer than for patients with lower levels (P = 0.003). In a multivariate analysis, c-erbB-2 oncoprotein lost its prognostic information, while tumour stage and tumour grade were identified as independent prognostic factors.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9184185      PMCID： PMC2223523          DOI： 10.1038/bjc.1997.284

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  26 in total

1.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

Authors:  M J van de Vijver; J L Peterse; W J Mooi; P Wisman; J Lomans; O Dalesio; R Nusse
Journal:  N Engl J Med       Date:  1988-11-10       Impact factor: 91.245

2.  Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.

Authors:  M Yao; T Shuin; H Misaki; Y Kubota
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

3.  The results of radical nephrectomy for renal cell carcinoma.

Authors:  C J Robson; B M Churchill; W Anderson
Journal:  J Urol       Date:  1969-03       Impact factor: 7.450

Review 4.  Prognostic factors in renal cancer.

Authors:  J B Thrasher; D F Paulson
Journal:  Urol Clin North Am       Date:  1993-05       Impact factor: 2.241

5.  Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.

Authors:  D J Venter; N L Tuzi; S Kumar; W J Gullick
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

6.  Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis.

Authors:  G Stumm; S Eberwein; S Rostock-Wolf; H Stein; S Pomer; J Schlegel; R Waldherr
Journal:  Int J Cancer       Date:  1996-02-20       Impact factor: 7.396

7.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

8.  The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.

Authors:  A L Schechter; M C Hung; L Vaidyanathan; R A Weinberg; T L Yang-Feng; U Francke; A Ullrich; L Coussens
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

Review 9.  Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.

Authors:  R Lupu; M Cardillo; L Harris; M Hijazi; K Rosenberg
Journal:  Semin Cancer Biol       Date:  1995-06       Impact factor: 15.707

10.  Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer.

Authors:  H Kandl; L Seymour; W R Bezwoda
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.